These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14609269)

  • 1. Experimental infection of calves with bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminated vaccine.
    Falcone E; Cordioli P; Tarantino M; Muscillo M; Sala G; La Rosa G; Archetti IL; Marianelli C; Lombardi G; Tollis M
    Vet Res Commun; 2003 Oct; 27(7):577-89. PubMed ID: 14609269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between health and productivity in cow-calf beef herds and persistent infection with bovine viral diarrhea virus, antibodies against bovine viral diarrhea virus, or antibodies against infectious bovine rhinotracheitis virus in calves.
    Waldner CL; Kennedy RI
    Am J Vet Res; 2008 Jul; 69(7):916-27. PubMed ID: 18593246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of a virulent type 2 bovine viral diarrhea virus.
    Deregt D; Jacobs RM; Carman PS; Tessaro SV
    Vet Microbiol; 2004 Jun; 100(3-4):151-61. PubMed ID: 15145494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of acute infection of calves exposed to a high-virulence or low-virulence bovine viral diarrhea virus or a HoBi-like virus.
    Ridpath JF; Falkenberg SM; Bauermann FV; VanderLey BL; Do Y; Flores EF; Rodman DM; Neill JD
    Am J Vet Res; 2013 Mar; 74(3):438-42. PubMed ID: 23438120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HoBi-Like Virus RNA Detected in Foetuses Following Challenge of Pregnant Cows that had Previously Given Birth to Calves Persistently Infected with Bovine Viral Diarrhoea Virus.
    Bauermann FV; Falkenberg SM; Ridpath JF
    Transbound Emerg Dis; 2017 Oct; 64(5):1624-1632. PubMed ID: 27615437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses.
    Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH
    Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.
    Fulton RW; Ridpath JF; Saliki JT; Briggs RE; Confer AW; Burge LJ; Purdy CW; Loan RW; Duff GC; Payton ME
    Can J Vet Res; 2002 Jul; 66(3):181-90. PubMed ID: 12146890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Occurrence of a Commercial N
    Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
    Viruses; 2018 May; 10(5):. PubMed ID: 29783722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2.
    Makoschey B; Janssen MG; Vrijenhoek MP; Korsten JH; Marel P
    Vaccine; 2001 Apr; 19(23-24):3261-8. PubMed ID: 11312023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bovine viral diarrhea associated with extensive mucosal lesions, high morbidity, and mortality in a commercial feedlot.
    Hessman BE; Sjeklocha DB; Fulton RW; Ridpath JF; Johnson BJ; McElroy DR
    J Vet Diagn Invest; 2012 Mar; 24(2):397-404. PubMed ID: 22379057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between degree of viremia and disease manifestation in calves with experimentally induced bovine viral diarrhea virus infection.
    Walz PH; Bell TG; Wells JL; Grooms DL; Kaiser L; Maes RK; Baker JC
    Am J Vet Res; 2001 Jul; 62(7):1095-103. PubMed ID: 11453486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of skin samples for bovine viral diarrhea virus by use of reverse transcriptase polymerase chain reaction assay after vaccination of cattle with a modified-live bovine viral diarrhea virus vaccine.
    Corbett EM; Grooms DL; Bolin SR
    Am J Vet Res; 2012 Feb; 73(2):319-24. PubMed ID: 22280397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaccination and challenge with bovine viral diarrhea virus (BVDV) of calves previously infected with a non-cytopathic BVDV.
    Castrucci G; Frigeri F; Ferrari M; Traldi V
    Comp Immunol Microbiol Infect Dis; 1991; 14(1):31-8. PubMed ID: 1647929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.